BioNTech SE (22UA) — Financial Flexibility Index
BioNTech SE (22UA) has a Financial Flexibility Index of -0.14x as of March 2026. Free cash flow of €-342.10 Million (operating CF €-421.00 Million minus capex €78.90 Million) represents 0% of total liabilities (€2.38 Billion). Check 22UA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioNTech SE Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for BioNTech SE across 9 annual periods. See 22UA current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BioNTech SE (2017–2025)
Year-by-year free cash flow to debt coverage for BioNTech SE. For the full company profile including market capitalisation, see market value of BioNTech SE.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | €1.21 Billion | €456.00 Million | €2.76 Billion | ▲ +106.0% |
| 2024 | 0.21x | €660.00 Million | €207.70 Million | €3.12 Billion | ▼ -90.4% |
| 2023 | 2.20x | €6.08 Billion | €5.37 Billion | €2.76 Billion | ▼ -49.1% |
| 2022 | 4.32x | €13.94 Billion | €13.58 Billion | €3.22 Billion | ▲ +1573.9% |
| 2021 | 0.26x | €1.02 Billion | €889.70 Million | €3.94 Billion | ▲ +365.9% |
| 2020 | 0.06x | €52.50 Million | €-13.50 Million | €946.77 Million | ▲ +110.5% |
| 2019 | -0.53x | €-159.90 Million | €-198.50 Million | €304.15 Million | ▼ -600.3% |
| 2018 | -0.08x | €-28.98 Million | €-58.88 Million | €385.99 Million | ▼ -12.4% |
| 2017 | -0.07x | €-28.24 Million | €-52.56 Million | €422.92 Million | — |